Drug Information

Drug General Information
Drug ID
D0W7UN
Former ID
DNCL003147
Drug Name
BI-409306
Indication Psychiatric disorder [ICD9: 290-319; ICD10:F01-F99] Phase 2 [524914]
Company
Boehringer Ingelheim Pharmaceuticals
Target and Pathway
Target(s) Phosphodiesterase (PDE) 9 Target Info Inhibitor [551883]
KEGG Pathway Purine metabolism
Pathway Interaction Database Regulation of Androgen receptor activity
Reactome cGMP effects
References
Ref 524914ClinicalTrials.gov (NCT02240693) Alzheimer Disease Proof of Concept Study With BI 409306 Versus Placebo. U.S. National Institutes of Health.
Ref 551883Clinical pipeline report, company report or official report of Boehringer Ingelheim pipeline.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.